[Possibilities of drug therapy of arrhythmias in myocardial infarct].
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D003325:Coronary Care Units; D004071:Digitalis Glycosides / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications*; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use; D014325:Tromethamine / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D013565:Sympatholytics; D014325:Tromethamine; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide
Moznosti léceni arytmii u infarktu myokardu farmaky.